The invention relates to compounds of formula (I) inhibiting phosphoinositide 3-kinases (PI3K), to pharmaceutical compositions comprising them, and to therapeutic uses thereof in the treatment of disorders associated with PI3K enzymes such as respiratory diseases, allergic diseases, autoimmune diseases or inflammatory disorders.Cette invention concerne des composés de formule (I) inhibant les phosphoinositide 3-kinases (PI3K), des compositions pharmaceutiques les contenant, et leurs utilisations thérapeutiques pour traiter les troubles associés aux enzymes PI3K tels que les maladies respiratoires, les maladies allergiques, les maladies auto-immunes ou les troubles inflammatoires.
